8-[4-[3-(3-tert-butyl-1-phenylpyrazol-5-yl)-2-oxopropyl]-3-fluorophenoxy]-4H-pyrido[2,3-b]pyrazin-3-one
C29H26FN5O3 — CID 147343338
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[4-[3-(3-tert-butyl-1-phenylpyrazol-5-yl)-2-oxopropyl]-3-fluorophenoxy]-4H-pyrido[2,3-b]pyrazin-3-one
8-[4-[3-(3-tert-butyl-1-phenylpyrazol-5-yl)-2-oxopropyl]-3-fluorophenoxy]-4H-pyrido[2,3-b]pyrazin-3-one (PubChem CID 147343338) has the molecular formula C29H26FN5O3 and a molecular weight of 511.56 g/mol. Its IUPAC name is 8-[4-[3-(3-tert-butyl-1-phenylpyrazol-5-yl)-2-oxopropyl]-3-fluorophenoxy]-4H-pyrido[2,3-b]pyrazin-3-one.
Molecular Properties
| Compound Name | 8-[4-[3-(3-tert-butyl-1-phenylpyrazol-5-yl)-2-oxopropyl]-3-fluorophenoxy]-4H-pyrido[2,3-b]pyrazin-3-one |
|---|---|
| PubChem CID | 147343338 |
| Molecular Formula | C29H26FN5O3 |
| Molecular Weight | 511.56 g/mol |
| Exact Mass | 511.20 |
| IUPAC Name | 8-[4-[3-(3-tert-butyl-1-phenylpyrazol-5-yl)-2-oxopropyl]-3-fluorophenoxy]-4H-pyrido[2,3-b]pyrazin-3-one |
| SMILES | CC(C)(C)c1cc(CC(=O)Cc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(-c2ccccc2)n1 |
| InChI | InChI=1S/C29H26FN5O3/c1-29(2,3)25-15-20(35(34-25)19-7-5-4-6-8-19)14-21(36)13-18-9-10-22(16-23(18)30)38-24-11-12-31-28-27(24)32-17-26(37)33-28/h4-12,15-17H,13-14H2,1-3H3,(H,31,33,37) |
| InChIKey | DDYBAYFPPCLPIJ-UHFFFAOYSA-N |
| XLogP | 5.09 |
| TPSA | 102.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 511.56 |
| LogP ≤ 5 | 5.09 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 147343338 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.